| 000 | 01220 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513021211.0 | ||
| 264 | 0 | _c19820412 | |
| 008 | 198204s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00140a021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacob, J N | |
| 245 | 0 | 0 |
_aDopamine agonist properties of N-alkyl-4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cAug 1981 |
||
| 300 |
_a1013-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDopamine Antagonists |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aIsoquinolines _xchemical synthesis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNomifensine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aRenal Artery _xphysiology |
| 650 | 0 | 4 | _aVasodilator Agents |
| 650 | 0 | 4 |
_aVasomotor System _xdrug effects |
| 700 | 1 | _aNichols, D E | |
| 700 | 1 | _aKohli, J D | |
| 700 | 1 | _aGlock, D | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 24 _gno. 8 _gp. 1013-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00140a021 _zAvailable from publisher's website |
| 999 |
_c7328106 _d7328106 |
||